Today's pharmacovigilance and risk management professionals must utilize best practices in current daily operations while anticipating coming changes associated with new therapies and technologies. At DIA's Pharmacovigilance and Risk Management Strategies Conference, you'll meet renowned hepatologist Professor Hervé Le-Louet, PhD, who will discuss findings that are helping to improve the assessment process of drug-induced liver injury and yielding clues to the prediction of this adverse drug reaction.

You will also hear from Keynote Speaker, Steven J. Murray, PhD, PE, Group Vice President and Principal Engineer at Exponent. He'll share insights on understanding product risk in the context of benefits and how this understanding and human factors of behavior inform product and risk management regulation. Developed by recognized experts from the biopharmaceutical industry and global regulatory agencies, this conference provides the background, context, and opportunities to discuss current challenges and to problem-solve around issues that matter most to professionals working in the field today.